Pregled bibliografske jedinice broj: 6740
Phenotypic analysis of receptor-ligand pairs on B-cells in B-chronic lymphocytic leukemia
Phenotypic analysis of receptor-ligand pairs on B-cells in B-chronic lymphocytic leukemia // Leukemia and lymphoma, 25 (1997), 3-4; 301-311 (međunarodna recenzija, članak, znanstveni)
CROSBI ID: 6740 Za ispravke kontaktirajte CROSBI podršku putem web obrasca
Naslov
Phenotypic analysis of receptor-ligand pairs on B-cells in B-chronic lymphocytic leukemia
Autori
Gagro, Alenka ; Dašić, Gorana ; Sabioncello, Ante ; Rabatić, Sabina ; Reckzeh, Barbara ; Havemann, Klaus ; Kardum, Ika ; Jakšić, Branimir ; Vitale, Branko
Izvornik
Leukemia and lymphoma (1042-8194) 25
(1997), 3-4;
301-311
Vrsta, podvrsta i kategorija rada
Radovi u časopisima, članak, znanstveni
Ključne riječi
chronic lymphocytic leukemia; immunophenotype; receptor ligand pairs
Sažetak
Whole-blood three-color immunofluorescence analysis was used to investigate the role of CD5/CD72 and CD21/CD23 receptor-ligand pair formation on B-chronic lymphocytic leukemia (B-CLL) cells as well as sCD23 and bcl-2 oncoprotein expression in disease progression and activity and total tumor mass in B-cell chronic leukemia (B-CLL) patients. Thirty-four patients with B-CLL and 19 controls were included in the study. The majority of B-cells in B-CLL patients coexpressed CD5 and CD72 as well as the CD23 antigen. Unlike B-cells in B-CLL patients, B-cells in all healthy controls tested had high expression of CD21 antigen. We identified two groups of B-CLL patients according to high (n = 20) or low levels (n = 14) of CD21 expression on CD19+CD23+ B-cells. Only in the patients with high CD21 expression, were sCD23 levels positively correlated with factors known to have prognostic significance in B-CLL (Rai stage and TTM) and could, therefore, be used as a prognostic parameter for these B-CLL patients. Bcl-2 oncoprotein expression did not differ between these patient groups. We presumed that in patients with a lower expression of CD21 antigen, the contribution of the CD21 molecule to homotypic adhesion was lacking. Further studies are necessary to determine the possible association of higher expression of the CD21 antigen with disease progression and the aggressive character of the B-CLL.
Izvorni jezik
Engleski
Znanstvena područja
Temeljne medicinske znanosti, Kliničke medicinske znanosti
POVEZANOST RADA
Ustanove:
Imunološki zavod d.d.,
Institut "Ruđer Bošković", Zagreb,
Medicinski fakultet, Zagreb
Profili:
Gorana Dašić
(autor)
Ika Kardum-Skelin
(autor)
Branimir Jakšić
(autor)
Ante Sabioncello
(autor)
Branko Vitale
(autor)
Alenka Gagro
(autor)
Sabina Rabatić
(autor)
Citiraj ovu publikaciju:
Časopis indeksira:
- Current Contents Connect (CCC)
- Web of Science Core Collection (WoSCC)
- Science Citation Index Expanded (SCI-EXP)
- SCI-EXP, SSCI i/ili A&HCI
- Scopus
- MEDLINE